Overview of the European and North American studies on HPV testing in primary cervical cancer screening
about
Role of human papillomaviruses in carcinogenesisAmerican Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerCervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choicesAmerican Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.New strategies for human papillomavirus-based cervical screeningEnhancing cancer care in areas of limited resources: our next stepsCurrent Technologies and Recent Developments for Screening of HPV-Associated Cervical and Oropharyngeal Cancers.Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda.Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopyComparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study.Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data.Quantifying mRNA and microRNA with qPCR in cervical carcinogenesis: a validation of reference genes to ensure accurate dataHuman papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis.Visual inspection with acetic acid as a cervical cancer test: accuracy validated using latent class analysis.New paradigms in cervical cancer prevention: opportunities and risks.Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data.A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study.Pooled analysis on the necessity of random 4-quadrant cervical biopsies and endocervical curettage in women with positive screening but negative colposcopyAnalysis of genetic copy number changes in cervical disease progression.A cross-sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11,064 Chinese womenEvaluation of microRNA-205 expression as a potential triage marker for patients with low-grade squamous intraepithelial lesionsA multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer.The role of MALAT1 correlates with HPV in cervical cancer.Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage.Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach.Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study.Cervical cancer prevention: new tools and old barriersPersistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysisHigh-grade cervical lesions among women attending a reference clinic in Brazil: associated factors and comparison among screening methods.Factors associated with future commitment and past history of human papilloma virus vaccination among female college students in northern Taiwan.Comparing the Cervista HPV HR test and Hybrid Capture 2 assay in a Dutch screening population: improved specificity of the Cervista HPV HR test by changing the cut-off.Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples.Canadian oncogenic human papillomavirus cervical infection prevalence: systematic review and meta-analysisClinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer.Increase in viral load, viral integration, and gain of telomerase genes during uterine cervical carcinogenesis can be simultaneously assessed by the HPV 16/18 MLPA-assay.Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature.MassARRAY spectrometry is more sensitive than PreTect HPV-Proofer and consensus PCR for type-specific detection of high-risk oncogenic human papillomavirus genotypes in cervical cancer.Detection of TERC amplification in cervical epithelial cells for the diagnosis of high-grade cervical lesions and invasive cancer: a multicenter study in China.
P2860
Q22305628-EB86A4F9-613E-49C3-BA99-359763B7D01CQ24607403-181BBE1D-994E-46A6-BD0C-EDC85CC528DFQ26775085-BF6BCB88-1103-4BA0-9A1B-576611E9FD3AQ26828840-1D3CBABF-8CEC-448F-9232-129AB40C2591Q26851699-32C44437-ABBE-4896-B9AF-2032D1CC4E61Q26861387-4BE7F328-23C7-47A4-8BD5-FE6747E1B9CEQ28072364-BD2CEC19-D996-45A1-A332-DC2CCAE37766Q30388952-67E54620-1B88-471C-B7F0-DE53152090F1Q30412457-98F6E85C-09EA-4745-9A87-37AC9B4171CDQ30423690-1E6DD770-469D-4B95-986F-C518A0726C3AQ30487807-AB70C0F8-4666-4A05-8B98-4CA818278950Q30863996-A6BB3EDE-F037-48B0-AC67-D8197856F24FQ30866975-8C87CC1C-C003-4E80-BDC5-EFA1DC5E7CEDQ30878077-AE1ED3D9-00EA-4875-9E26-5A4A901D31CCQ33292499-17C05291-7617-4BFF-8DC2-BB38091E9A7CQ33394011-769B49EB-C0C1-4E03-942A-CED7C8D0613FQ33488158-3A0203FB-8898-4768-AA23-2E5857FD4F15Q33580897-5769EA27-887D-4F4C-8706-8A0F6B600285Q33627102-80C872CF-06F6-492B-91E7-1B3D6BB34D8AQ33659642-C5C60B3A-0C6D-452D-B705-A8A9C5884BB3Q33679663-C60D4C61-5605-46A1-AF42-F49F8E30621FQ33685531-78CB68C9-DBBD-4354-A33D-CAF1A1C968F2Q33718190-57F27355-189E-49BD-AD07-7BD3CE2A957EQ33727807-0741282F-555A-46AE-B8D8-6DE9083D3964Q33740118-CED26409-60FE-4E37-B60F-45CDC0C8BFE6Q33746081-5A2FA4F5-3973-4948-B244-A37BC60F650CQ33771876-C19849C6-44EA-475F-810A-E2A2AC9411DDQ33834332-8A54D58A-FD86-458B-8422-39A8057F31FEQ33875895-E0447906-F0E8-40EA-A819-5B3640EA9C4BQ33883532-8F77886A-6B32-4C6B-9B2D-CBA4229509A2Q33890037-DEB7A492-8DE1-4476-A803-39F8CB8FD32AQ33917319-ADBDB393-2357-4DF4-93BD-EF313A33E807Q33933176-A188BC34-0340-4154-8958-F1E26AADACAAQ33969401-CBBBEB34-B75D-4288-9435-B43FC79BE682Q34011249-A3458877-D56A-4825-8E8B-56A0F3F473E2Q34046296-BBE5FDEF-5CF0-49EE-BD54-4F56EF712BAFQ34162496-F0C38CA5-80B3-40B4-8B2F-3C6C65B589B8Q34173407-74B5F556-6322-4320-A575-2CD17DAA864DQ34205793-195D5BC1-90F8-48AB-A33C-3263739BB58AQ34239710-516950D5-8313-4B85-9AC2-C52A89FB18C6
P2860
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
description
im Januar 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2006
@uk
name
Overview of the European and N ...... mary cervical cancer screening
@en
Overview of the European and N ...... mary cervical cancer screening
@nl
type
label
Overview of the European and N ...... mary cervical cancer screening
@en
Overview of the European and N ...... mary cervical cancer screening
@nl
prefLabel
Overview of the European and N ...... mary cervical cancer screening
@en
Overview of the European and N ...... mary cervical cancer screening
@nl
P2093
P356
P1476
Overview of the European and N ...... mary cervical cancer screening
@en
P2093
Chris J.L.M. Meijer
Christine Clavel
Heike Hoyer
Jack Cuzick
Karl-Ulrich Petry
Philippe Birembaut
Samuel Ratnam
Shalini Kulasingam
Thomas Iftner
P2860
P304
P356
10.1002/IJC.21955
P577
2006-01-01T00:00:00Z